high intensity functional training for Parkinson's (NCT06879821)
Improve everyday movement and thinking
- Trial ID
- NCT06879821
- Official Title
- Effectiveness of a High-intensity Functional Training (HIFT) Program on Functional and Cognitive Performance in People with Parkinson's Disease.
- Goal
- Improve everyday movement and thinking
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Fundacion Para La Investigacion Hospital La Fe
- Study Type
- INTERVENTIONAL
- Enrollment
- 34 participants
- Conditions
- Parkinson Disease
- Interventions
- high intensity functional training
Summary For Families
They're testing whether a high-intensity functional training program can improve everyday movement and thinking skills in people with early Parkinson's. HIFT is a supervised exercise routine that mixes strength, cardio, balance, and task-specific movements done at higher intensity to boost muscle power, endurance, balance, and brain plasticity, and it is intended to complement usual Parkinson's medications like levodopa rather than replace them. The trial is looking for adults about 45 to 80 years old with early stage Parkinson's (Hoehn and Yahr I or II) who can walk independently for 10 minutes and already exercise regularly; people who are sedentary, have serious balance or sensory problems, severe cognitive or psychotic disorders, recent surgery, or medical reasons preventing intense exercise are excluded.
Locations
- University of Valencia, Valencia, Valencia, Spain
Frequently Asked Questions
- What is this trial testing?
- This trial is studying high intensity functional training. They're testing whether a high-intensity functional training program can improve everyday movement and thinking skills in people with early Parkinson's. HIFT is a supervised exercise routine that mixes strength, cardio, balance, and task-specific movements done at higher intensity to boost muscle power, endurance, balance, and brain plasticity, and it is intended to complement usual Parkinson's medications like levodopa rather than replace them. The trial is looking for adults about 45 to 80 years old with early stage Parkinson's (Hoehn and Yahr I or II) who can walk independently for 10 minutes and already exercise regularly; people who are sedentary, have serious balance or sensory problems, severe cognitive or psychotic disorders, recent surgery, or medical reasons preventing intense exercise are excluded.
- Who can participate?
- Participants must be between 40 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 9 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This trial has a group that receives no study treatment (you would continue your usual care) alongside the treatment group. Because assignment is random, you have about a 1 in 2 chance (roughly 50%) of being in the no-treatment group, assuming the groups are filled equally. Ask the coordinator to confirm the exact assignment ratio.
- How many visits does this trial involve?
- Participants in the experimental group will attend training sessions twice a week for 10 weeks.